Four Klebsiella pneumoniae isolates from children hospitalized over 10 months in an intensive care unit in a children's teaching hospital in Poland were analyzed. All of the isolates belonged to a single pulsotype and sequence type (ST) 11, and produced the KPC2 carbapenemase and extendedspectrum βlactamase (ESBL) CTXM15. They were resistant to a variety of antimicrobials, and their βlactam resistance patterns were typical for KPC producers. This is one of few cases of identification of KPC (or carbapenemase)producing K. pneumoniae in a pediatric center in Poland.
In recent years resistance to carbapenems has become a matter of the highest concern in medicine of bacterial infections (Bush, 2010; Nordmann and Poirel, 2014) . It has been associated largely with carba penemaseproducing Enterobacteriaceae which express various carbapenemhydrolyzing enzymes, includ ing Klebsiella pneumoniae carbapenemases (KPCs) (MunozPrice et al., 2013; Nordmann and Poirel, 2014) . KPCs hydrolyze virtually all βlactams of clinical use (Mehta et al., 2015) , and are produced by many species, predominantly by K. pneumoniae. Strains with KPCs disseminate rapidly and cause outbreaks; since the late 1990s these have spread in the United States, followed by Israel from 2005, and then worldwide (MunozPrice et al., 2013; Nordmann and Poirel, 2014) . In large part, this has been due to clonal expansion of K. pneumoniae strains belonging to the sequence type (ST) 258 and related clones, forming the clonal group (CG) 258 (Chen et al., 2014; Mathers et al., 2015) . bla KPC genes, mainly bla KPC2 or bla KPC3 , are carried by Tn4401 like transposons of some structural polymorphism (Naas et al., 2008; Baraniak et al., 2015) . Most KPC producing bacteria also express other βlactamases and contain genes conferring resistance to other anti microbials, such as aminoglycosides, fluoroquinolones or cotrimoxazole (Nordmann and Poirel, 2014) . There fore, infections caused by multidrugresistant KPC pro ducers have scarce treatment options and are associated with high mortality rates (Tumbarello et al., 2015) .
KPC2producing K. pneumoniae ST258 emerged in Poland in 2008 (Baraniak et al., 2009) and by the end of 2009 it caused a large outbreak in Warsaw and its region, Mazowieckie (Baraniak et al., 2011) . At the same time sporadic cases of other STs of K. pneumoniae with KPC2, namely ST11 and ST23, were observed in Warsaw and Kielce, respectively. All bla KPC2 genes identified were located within the Tn4401a trans poson variant. In 2010-2014 still the most affected region was Mazowieckie but new KPC outbreaks occurred in four other areas: Świętokrzyskie, Lubel skie, Podlaskie and Śląskie (Baraniak et al., 2017) . The outbreak organisms were K. pneumoniae ST258 or ST512 and they produced KPC3 encoded by Tn4401a or Tn4401b elements. According to the National Refer ence Centre for Susceptibility Testing (NRCST) data, since 2014 the situation has had a tendency to stabi lize at a low prevalence level in most of the regions mentioned above (D. Żabicka, A. Baraniak, M. Gniad kowski, W. Hryniewicz, unpublished data).
In this study four KPCpositive K. pneumoniae isolates from children were analyzed. All patients were hospitalized between February and November 2016 in an intensive care unit (ICU) in a large tertiary pedia tric center in Kraków, and included chronologi cally: a 7yearsold female with aspiration pneumonia, a 2monthsold male with respiratory distress syn drome, a 9monthsold female with multiple organ failure, and a 6yearsold female with pneumonia. The K. pneumoniae isolates were recovered mainly from tracheal or bronchial aspirates; one isolate, 2214/16, was cultured from blood. The isolates were identified by the hospital microbiology laboratory, using the Phoenix system (BD Biosciences), and owing to car bapenem resistance these were sent to the NRCST in Warsaw for reference diagnostics and surveillance pur poses. The NRCST has confirmed carbapenem resist ance by the Carba NP test (Nordmann et al., 2012) , and the positive combined disk test with phenylboronic acid (Doi et al., 2008) and PCR (NavonVenezia et al., 2006) revealed the KPC presence.
KPC-2-producing
The isolates were typed using pulsedfield gel elec trophoresis (PFGE) (Seifert et al., 2005) , and produced identical DNA banding patterns. The following multi locus sequence typing (MLST) (Diancourt et al., 2005) classified them into ST11 (http://bigsdb.web.pasteur.fr/ klebsiella). Amplicons containing the bla KPC genes were digested by the RsaI restriction enzyme (Thermo Scien tific) which distinguishes the bla KPC2 and bla KPC3 like genes (Lopez et al., 2011) . All isolates carried the bla KPC2 like alleles, which turned out to be bla KPC2 by sequenc ing performed for the representative isolate 2214/16. A PCR mapping assay that discerns various polymorphs of the Tn4401 transposon (Naas et al., 2008; Baraniak et al., 2015) demonstrated the presence of the Tn4401a variant exclusively. Specific PCRs for major βlactamase types (Baraniak et al., 2011) allowed detecting addi tionally ESBLs of the CTXM1 group and TEMlike enzymes in all of the isolates, identified by sequencing as CTXM15 and TEM1, respectively, in the isolate 2214/16. Susceptibility of the KPCproducing K. pneumoniae was tested by MIC Test Strips (Liofilchem®) and by the broth microdilution method in the case of colistin (http://eucast.org). The results were inter preted according to the EUCAST guidelines (http:// eucast.org). The isolates showed multidrug resistance patterns, with uniform resistance to all βlactams, gen tamicin and ciprofloxacin, susceptibility only to amika cin, tigecycline and colistin (Table I) .
K. pneumoniae is a relatively frequent cause of nosocomial outbreaks, including those in neonatal or pediatric wards that are a matter of special concern (Paczosa and Mecsas, 2016) . The constantly and rap idly increasing resistance of this pathogen remarkably magnifies the problem. The NRCST data indicates that the carbapenemaseproducing multidrugresistant K. pneumoniae strains have been rarely observed in pediatric centers in Poland so far (D. Żabicka, A. Bara niak, M. Gniadkowski, W. Hryniewicz, unpublished data); therefore, the cases analyzed in this study might signalize the risk of their expansion into these environ ments. The high genetic relatedness of the four isolates suggests the epidemic character of the KPC infections in the ICU. However, the infection cases were separated in time from each other, and identification of each case was followed by implementation of enhanced infection control measures. It is possible that the outbreak was mediated by unidentified carrier(s) or a hidden envi ronmental source, but the repeated introduction of the KPC2producing K. pneumoniae ST11 organism can not be totally excluded either. Since November 2016 to the moment of writing this report (March 2017) no new KPC cases have been recorded in the hospital.
Interestingly, the isolates were not related to any of the outbreak or sporadic KPCproducing K. pneumoniae isolates ever studied in detail in Poland so far, predominantly representing various lineages of the CG258 group (Baraniak et al., 2009; 2017) . These comprised two KPC3positive ST512 isolates from another hospital in Kraków from 2012 (Baraniak et al., 2017) , as well as the only two "Polish" ST11 iso lates with KPC2 from 2009 from Warsaw (Baraniak et al., 2011) . ST11 is a truly pandemic K. pneumoniae clone, and an evolutionary precursor of ST258 (Chen et al., 2014) . It has been identified in many countries with a variety of resistance mechanisms, including diverse βlactamases, and for example in Poland it has CST  TGC  TET  CIP  GEN  AMK  ERT  MEM  IMP  ATM  FEP  CTX  TZP  PIP  AMC  AMX  CAZ 403 been responsible for a spectacular ongoing outbreak of New Delhi metalloβlactamase (NDM) producers (Baraniak et al., 2016) . KPCproducing K. pneumoniae ST11 has been identified in several countries, being the predominant KPC producer in China (Qi et al., 2011; Cheng et al., 2016; Hu et al., 2016) and playing a signifi cant role in Spain (Oteo et al., 2016) or Brazil (Pereira et al., 2013; Andrade et al., 2014) . The emergence of the KPC2producing ST11 in Kraków might be due to a new KPC introduction to Poland; considering the relatively low prevalence of KPCs in the country and especially in Kraków, the onsite transmission of a KPCencoding plasmid from a CG258 member to ST11 seems to be less likely. This work was financed by the National Medicines Institute internal funding (DS 5.27), SPUB MIK ROBANK from the Polish Ministry of Science and Higher Education, and Narodowy Program Ochrony Antybiotyków from the Polish Ministry of Health. We are thankful to other members of the NRCST and workers of the hospital microbiology laboratory for their excellent technical assistance.
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